Invention Grant
- Patent Title: Deuterated baricitinib
- Patent Title (中): 氘代baricitinib
-
Application No.: US14422049Application Date: 2013-08-15
-
Publication No.: US09540367B2Publication Date: 2017-01-10
- Inventor: Roger D. Tung
- Applicant: Concert Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: McCarter & English, LLP
- Agent Steven G. Davis
- International Application: PCT/US2013/055170 WO 20130815
- International Announcement: WO2014/028756 WO 20140220
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61P19/02 ; A61P35/04 ; A61P37/06 ; C07D471/04 ; A61P29/00 ; A61P3/10
Abstract:
The present invention in one embodiment provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.
Public/Granted literature
- US20150218158A1 DEUTERATED BARICITINIB Public/Granted day:2015-08-06
Information query
